Global Innovative Platforms Inc. cash flow statement GIPL

Annual Quarterly

In fiscal 2025, which ended Sep 30, 2025, Global Innovative Platforms Inc. used $560,740 of cash from operations, down 541.7% from the year before.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

FY 2026
Jun 30, 2026
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
FY 2023
Sep 30, 2023
FY 2022
Sep 30, 2022
FY 2021
Sep 30, 2021
Operating
Operating cash flow
-0
+39.7%
-1
-541.7%
-0
+62.8%
-0
-337.9%
-0
-20565.6%
0
Investing
Investing cash flow
—
-0
0
0
0
0
Financing
Financing cash flow
1
-8.6%
1
+766.9%
0
-53.6%
0
+85.4%
0
0
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
GIPL (OTC)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Maitland, FL
SEC filer status
, Emerging growth company
SEC CIK
1837774
Former names
Canning Street Corp (until Sep 10, 2021)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.